Sign In
Buy SCPS
$0.0004
+0 (+0%)
At Close: Jun 22, 2026
Scopus BioPharma Earnings Calls
Mar 31, 2026
| Release date | Jun 03, 2026 |
| EPS estimate | -$0.230 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2025
| Release date | Feb 25, 2026 |
| EPS estimate | -$0.220 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Jun 30, 2023
| Release date | Aug 11, 2023 |
| EPS estimate | - |
| EPS actual | -$0.0658 |
| Revenue estimate | - |
| Revenue actual | - |
Mar 31, 2023
| Release date | May 12, 2023 |
| EPS estimate | - |
| EPS actual | -$0.0807 |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Scopus BioPharma
Below you can see how SCPS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Mar 31, 2023
| Release date | May 12, 2023 |
| Price on release | $0.0700 |
| EPS estimate | - |
| EPS actual | -$0.0807 |
| Date | Price |
|---|---|
| May 08, 2023 | $0.0500 |
| May 09, 2023 | $0.0600 |
| May 10, 2023 | $0.0750 |
| May 11, 2023 | $0.0700 |
| May 12, 2023 | $0.0700 |
| May 15, 2023 | $0.0700 |
| May 16, 2023 | $0.0700 |
| May 17, 2023 | $0.0900 |
| May 18, 2023 | $0.0620 |
| 4 days before | 40.00% |
| 4 days after | -11.43% |
| On release day | 0% |
| Change in period | 24.00% |
Jun 30, 2023
| Release date | Aug 11, 2023 |
| Price on release | $0.0490 |
| EPS estimate | - |
| EPS actual | -$0.0658 |
| Date | Price |
|---|---|
| Aug 07, 2023 | $0.0400 |
| Aug 08, 2023 | $0.0400 |
| Aug 09, 2023 | $0.0570 |
| Aug 10, 2023 | $0.0570 |
| Aug 11, 2023 | $0.0490 |
| Aug 14, 2023 | $0.0310 |
| Aug 15, 2023 | $0.0310 |
| Aug 16, 2023 | $0.0310 |
| Aug 17, 2023 | $0.0310 |
| 4 days before | 22.50% |
| 4 days after | -36.73% |
| On release day | -36.73% |
| Change in period | -22.50% |
Dec 31, 2025
| Release date | Feb 25, 2026 |
| Price on release | $0.0004 |
| EPS estimate | -$0.220 |
| EPS actual | - |
| Date | Price |
|---|---|
| Feb 19, 2026 | $0.0004 |
| Feb 20, 2026 | $0.0004 |
| Feb 23, 2026 | $0.0004 |
| Feb 24, 2026 | $0.0004 |
| Feb 25, 2026 | $0.0004 |
| Feb 26, 2026 | $0.0004 |
| Feb 27, 2026 | $0.0004 |
| Mar 02, 2026 | $0.0004 |
| Mar 03, 2026 | $0.0004 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Mar 31, 2026
| Release date | Jun 03, 2026 |
| Price on release | $0.0004 |
| EPS estimate | -$0.230 |
| EPS actual | - |
| Date | Price |
|---|---|
| May 28, 2026 | $0.0004 |
| May 29, 2026 | $0.0004 |
| Jun 01, 2026 | $0.0004 |
| Jun 02, 2026 | $0.0004 |
| Jun 03, 2026 | $0.0004 |
| Jun 04, 2026 | $0.0006 |
| Jun 05, 2026 | $0.0006 |
| Jun 08, 2026 | $0.0006 |
| Jun 09, 2026 | $0.0004 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 50.00% |
| Change in period | 0% |
Scopus BioPharma Earnings History
Earnings Calendar
FAQ
When is the earnings report for SCPS?
Scopus BioPharma Inc. (SCPS) has scheduled its earnings report for Sep 02, 2026 after the markets close.
What is the SCPS price-to-earnings (P/E) ratio?
SCPS P/E ratio as of Jun 22, 2026 (TTM) is -0.0007.
What is the SCPS EPS forecast?
The forecasted EPS (Earnings Per Share) for Scopus BioPharma Inc. (SCPS) for the first fiscal quarter 2026 is -$0.230.
What are Scopus BioPharma Inc.'s retained earnings?
On its balance sheet, Scopus BioPharma Inc. reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
